Home/ Crypto News/ AstraZeneca (AZN) Stock Gains Momentum Following CEO Share Purchase and European Drug Approval

blockonomi 10 hours ago

AstraZeneca (AZN) Stock Gains Momentum Following CEO Share Purchase and European Drug Approval

Stocks

AstraZeneca (AZN) stock gains 0.63% after CEO purchases £7.26M in shares and EU recommends Klygefa approval for rare autoimmune disorder treatment.

The post AstraZeneca (AZN) Stock Gains Momentum Following CEO Share Purchase and European Drug Approval appeared first on Blockonomi.

Source: Source: Blockonomi